Yıl: 2023 Cilt: 4 Sayı: 1 Sayfa Aralığı: 6 - 13 Metin Dili: İngilizce DOI: 10.59213/TP.2023.55265 İndeks Tarihi: 08-05-2023

The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children

Öz:
Objective: Children with congenital heart disease are at risk of malnutrition due to inadequate calorie intake, increased energy expenditure, pulmonary infections, and malabsorption. The aim of this study was to investigate the changes in appetite, nutritional hormones, and anthropometric measurements before and after the transcatheter closure of the atrial septal defect. Method: The study included 27 patients whose atrial septal defect closed percutaneously and 25 children as a healthy control group. The initial symptoms, anthropometric measurements, and laboratory tests were recorded initially, and 1 month and 6 months after the closure. Results: The mean age of patients and control group were 88.29 ± 58.25 months, 86.52 ± 55.81 months respectively. At the 1st month after the closure, all the symptoms in the patient group decreased compared to the initial visit except rapid breathing (p <0.05). The percentage of patients who had a lack of appetite decreased from 45% to 5% at the 1st month visit. After the closure, the increase in weight for age, body mass index, and z-score were statistically significant at the 1st and 6th months (p <0.05). Insulin-like growth factor-1 levels increased compared to the initial values at the 1st month (p =0.016). A linear decrease in ghrelin levels and a linear increase in leptin levels were observed in the atrial septal defect group during the 6-month follow-up after the closure. Conclusion: Children with atrial septal defect are at the risk of malnutrition. The primary prevention of malnutrition should be the goal of our treatment plan for these children; the timing of the interventional treatment is critical and has to be before the development of malnutrition.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60. [Crossref]
  • 2. Kimura D, McNamara IF, Wang J, Fowke JH, West AN, Philip R. Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness. Cardiol Young. 2019;29:615-9. [Crossref]
  • 3. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone- releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255-61. [Crossref]
  • 4. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141:4325-8. [Crossref]
  • 5. Mondal MS, Date Y, Yamaguchi H, et al. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept. 2005;126:55- 9. [Crossref]
  • 6. Kitamura T, Shimizu T, Ohkawa N, Oda H, Ohtsuki M, Kishiro M. Effects of ghrelin on growth and cardiac function in infants with congenital heart disease. Pediatr Int. 2010;52:358-61. [Crossref]
  • 7. Toshinai K, Date Y, Murakami N, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology. 2003;144:1506-12. [Crossref]
  • 8. Kandil ME, Elwan A, Hussein Y, Kandeel W, Rasheed M. Ghrelin levels in children with congenital heart disease. J Trop Pediatr. 2009;55:307-12. [Crossref]
  • 9. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483-7. [Crossref]
  • 10. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104:2034-8. [Crossref]
  • 11. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism. 1997;46:450-3. [Crossref]
  • 12. Barton JS, Hindmarsh PC, Preece MA. Serum insulin-like growth factor 1 in congenital heart disease. Arch Dis Child. 1996;75:162-3. [Crossref]
  • 13. Kerpel-Fronius E, Kiss S, Kardos G, Gács G. Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption. Monatsschr Kinderheilkd (1902). 1977;125:783-6.
  • 14. Yılmaz R, Esmeray H, Erkorkmaz Ü. Adaptation study of the Turkish Children’s Eating Behavior Questionnaire. Alpha Psychiatry. 2011;12:287- 94.
  • 15. Guven B, Can M, Mungan G, Acіkgoz S. Reference values for serum levels of insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3) in the West Black Sea region of Turkey. Scand J Clin Lab Invest. 2013;73:135-40. [Crossref]
  • 16. Knop MT, Białkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol. 2018;76:1257-62. [Crossref]
  • 17. Sharma B, Pinto R, Dalvi B. Transcatheter closure of atrial septal defect in symptomatic children weighing ≤10 kg: Addressing unanswered issues from a decade of experience. Ann Pediatr Cardiol. 2020;13:4-10. [Crossref]
  • 18. Narin N, Baspinar O, Pamukcu O, et al. Percutaneous ASD closure of children weighing less than 10 kg. Acta Cardiol. 2020;75:631-6. [Crossref] 19. Mehrizi A, Drash A. Growth disturbance in congenital heart disease. J Pediatr. 1962;61:418-29. [Crossref]
  • 20. Yilmaz E, Ustundag B, Sen Y, Akarsu S, Citak Kurt AN, Dogan Y. The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease. Mediators Inflamm. 2007;2007:32403. [Crossref]
  • 21. Blasquez A, Clouzeau H, Fayon M, et al. Evaluation of nutritional status and support in children with congenital heart disease. Eur J Clin Nutr. 2016;70:528-31. [Crossref]
  • 22. Soliman AT, Elawwa A, Khella A, Saeed S, Yassin H. Linear growth in relation to the circulating concentration of insulin-like growth factor-I in young children with acyanotic congenital heart disease with left to right shunts before versus after surgical intervention. Indian J Endocrinol Metab. 2012;16:791-5. [Crossref]
  • 23. Surmeli-Onay O, Cindik N, Tulgar Kinik S, Ozkan S, Bayraktar N, Tokel K. The effect of corrective surgery on serum IGF-1, IGFBP-3 levels and growth in children with congenital heart disease. J Pediatr Endocrinol Metab. 2011;24:483-7. [Crossref]
  • 24. Hallioglu O, Alehan D, Kandemir N. Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters. Int J Cardiol. 2003;92:93-7. [Crossref]
APA Tasci O, Pamukcu O, Narin N, Barlak Keti D, Sunkak S, Vural Ç, Baykan A (2023). The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. , 6 - 13. 10.59213/TP.2023.55265
Chicago Tasci Onur,Pamukcu Ozge,Narin Nazmi,Barlak Keti Didem,Sunkak Suleyman,Vural Çağdaş,Baykan Ali The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. (2023): 6 - 13. 10.59213/TP.2023.55265
MLA Tasci Onur,Pamukcu Ozge,Narin Nazmi,Barlak Keti Didem,Sunkak Suleyman,Vural Çağdaş,Baykan Ali The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. , 2023, ss.6 - 13. 10.59213/TP.2023.55265
AMA Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. . 2023; 6 - 13. 10.59213/TP.2023.55265
Vancouver Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. . 2023; 6 - 13. 10.59213/TP.2023.55265
IEEE Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A "The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children." , ss.6 - 13, 2023. 10.59213/TP.2023.55265
ISNAD Tasci, Onur vd. "The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children". (2023), 6-13. https://doi.org/10.59213/TP.2023.55265
APA Tasci O, Pamukcu O, Narin N, Barlak Keti D, Sunkak S, Vural Ç, Baykan A (2023). The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics, 4(1), 6 - 13. 10.59213/TP.2023.55265
Chicago Tasci Onur,Pamukcu Ozge,Narin Nazmi,Barlak Keti Didem,Sunkak Suleyman,Vural Çağdaş,Baykan Ali The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics 4, no.1 (2023): 6 - 13. 10.59213/TP.2023.55265
MLA Tasci Onur,Pamukcu Ozge,Narin Nazmi,Barlak Keti Didem,Sunkak Suleyman,Vural Çağdaş,Baykan Ali The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics, vol.4, no.1, 2023, ss.6 - 13. 10.59213/TP.2023.55265
AMA Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics. 2023; 4(1): 6 - 13. 10.59213/TP.2023.55265
Vancouver Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children. Trends in Pediatrics. 2023; 4(1): 6 - 13. 10.59213/TP.2023.55265
IEEE Tasci O,Pamukcu O,Narin N,Barlak Keti D,Sunkak S,Vural Ç,Baykan A "The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children." Trends in Pediatrics, 4, ss.6 - 13, 2023. 10.59213/TP.2023.55265
ISNAD Tasci, Onur vd. "The effects of transcatheter atrial septal defect closure on appetite, nutritional hormones and growth in children". Trends in Pediatrics 4/1 (2023), 6-13. https://doi.org/10.59213/TP.2023.55265